MS-DETECT Purpose To enhance and standardize the remote monitoring of people living with Multiple Sclerosis (PwMS) in order to improve the assessment of disease worsening. Whether due to relapse-associated worsening (RAW) or progression independent of relapses (PIRA). This research will also be used to validate the clinical performance, safety, and usability of MSCopilot® Detect. It will also assess the satisfaction of both the patients, and healthcare professionals. Patient Population Adult patients living with Relapsing Remitting MS or Secondary Progressive MS, ages 30-65. Clinically stable patients experiencing minimal disability, isolated to at least two functional systems, to moderate disability including ambulatory difficulty with unilateral assistance. For more information, please click on the image to the left. Research Method MS-DETECT is an international, low-intervention, open clinical study. During the study, patients will be required to attend four visits at six-month intervals. If a patient is found to be progressing at 18 months, a fifth visit will be scheduled for the 24-month mark to confirm their progression. Patients will be asked to perform digital tests and e-questionnaires on their smartphones using the MSCopilot® Detect application, electronic Patient Reported Outcomes (ePROs) and Electronic Data Capture (EDC) system from home and in clinic. Clinical Trial Information https://clinicaltrials.gov/study/NCT05816122?term=ms-detect&rank=1 Status: Recruiting The MS-DETECT Study at the University of Texas at AustinLocation: UT Health Austin, MS and Neuroimmunology CenterDell Medical SchoolLocal site principal investigator: Leorah Freeman, MD, PhDResearch coordinators: Gabriella Cozzani, BSA; Alejandra Gomez-Lopez, BA Sponsor Ad Scientiam The image banner on this site is AI generated
